Hoth Therapeutics, a Nevada corporation, is a development stage biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis, also known as eczema.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 02/22/18 | $3,000,000 | Series A |
Laidlaw & Co. | undisclosed |
